ESC 365 - ACE inhibitors and ARBs decrease more powerful the PTX-3 plasma levels of hypertensive patients with endothelial dysfunction compared with other anti-hypertensive drugs, in a chronic treatment

ESC Premium Access

ACE inhibitors and ARBs decrease more powerful the PTX-3 plasma levels of hypertensive patients with endothelial dysfunction compared with other anti-hypertensive drugs, in a chronic treatment

Session: Poster session 3 - Vascular function as a target of cardiovascular therapy?

Topic: Drug therapy

Speaker: Ms V. Buda (Timisoara, RO)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Ms Valentina Buda

University of Medicine and Pharmacy Victor Babes, Timisoara (Romania)

0 follower

4 more presentations in this session

The influence of perindopril on endoglin plasma levels compared with other antihypertensive drugs, in a chronic treatment

Speaker: Doctor M. Andor (Timisoara, RO)

Effect of different types of combined antihypertensive therapy on central blood pressure and arterial stiffness in patients with moderate to severe arterial hypertension

Speaker: Doctor O. Torbas (Kiev, UA)

Dapagliflozin acutely restores endothelial function, reduces aortic stiffness and renal resistive index: a pilot study

Speaker: Professor R. Bruno (Paris, FR)

Phosphodiesterase type 5 activity limits tonic vasodilation mediated by neuronal nitric oxide synthase in the human forearm.

Speaker: Doctor F. Khan (London, GB)

Access the full session

Poster session 3 - Vascular function as a target of cardiovascular therapy?

Speakers: Ms V. Buda, Doctor M. Andor, Doctor O. Torbas, Professor R. Bruno, Doctor F. Khan

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources